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Abstract
Type 2 diabetes mellitus is characterized by impaired glucose uptake. With a photometric method of recording the
erythrocyte suspension absorption during the course of glucose transport across the membranes, we observed that the initial
rate of glucose zero-trans entry was decreased significantly in 30 Chinese type 2 diabetic patients as compared to 25 healthy
controls. The rate of glucose infinite-cis efflux exhibited no difference between the patients and controls. The measurement of
temperature dependence of glucose transport showed that the activation energy for glucose entry was increased in diabetic
patients. The inhibitory constant of glucose entry by cytochalasin B (CB) in patients was similar to that of the controls.
However, we found that the inhibitory constant was increased significantly in the patient erythrocytes after phloretin
treatment. After the erythrocytes were made into stripped white ghosts, the fluorescence quenching experiment was
performed. Glucose, CB and phloretin can quench the fluorescence of tryptophan residues in the glucose transporter 1,
GLUT1. The abnormality of fluorescence quenching in the erythrocyte membranes of patients was observed. The transfer
tendency of tryptophan residues from the hydrophilic environment to the hydrophobic environment was decreased in patient
ghosts as binding with glucose, and the opposite tendency appeared as CB and phloretin instead of glucose. We conclude that
the decreased in glucose entry in the erythrocyte membranes of diabetic patients was due to the GLUT1 change in structure ^
mostly the outer domain of the glucose transporter. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
In type 2 diabetes, normal glucose homeostasis
cannot be maintained because of insulin resistance
and an inadequate compensatory insulin secretion.
Chronic hyperglycemia is a characteristic of diabetes
disordered glucose metabolism. Glucose transporter
1 (GLUT1) presents in low levels in nearly all tissues.
With ¢ve other identi¢ed homologous glucose trans-
porter isoforms, GLUT1 plays pivotal roles in glu-
cose and its analogue metabolism and it is responsi-
ble for basal glucose uptake [1,2].
Glucose utilization occurs as a result of both in-
sulin-mediated glucose uptake and non-insulin-medi-
ated glucose uptake. It was indicated that reduction
in non-insulin-mediated glucose uptake plays an im-
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portant pathogenic role in disorders of carbohydrate
metabolism in diabetic patients [3]. Many studies
have addressed how glucose transporters might be
involved in the pathogenesis of diabetes. Though
mutations in the genes that constitute GLUT family
could explain some observed physiological defects in
type 2 diabetes, nearly all studies did not support this
attractive presumption [4^7].
The blood vessel should be regarded as the pri-
mary target organ in diabetes mellitus. In diabetic
patients, both the macrocirculation and microcircu-
lation are a¡ected [8,9]. GLUT1 is most abundant in
the erythrocytes. Besides, Concha et al. [10] reported
recently that the human erythrocytes also express the
GLUT5 hexose transporter, which operates primarily
as a fructose transporter. Because of lacking mito-
chondria and ribosomes, the content of GLU1 in
erythrocyte membrane is steady and there is no
new protein biosynthesis. So the erythrocyte is an
idle model to study the role of GLUT1 in glucose
metabolism in diabetes. Some studies [11^13] indi-
cated that glucose uptake was changed signi¢cantly
in the erythrocytes of diabetic patients, but the rea-
son of this change has not yet been de¢ned. In this
study, we attempted to determine an unambiguous
abnormality of glucose transport across the erythro-
cyte membranes in Chinese type 2 diabetic patients.
The most striking result that emerges from this study
is that the change in glucose transport was due to the
GLUT1 structure change ^ mostly the outer domain
of the glucose transporter.
2. Materials and methods
2.1. Materials
Freshly drawn Chinese type 2 diabetes patients’
(treated with diet and oral hypoglycemic) blood sam-
ples were obtained from the Xinhua Hospital in
Shanghai. The fresh healthy bloods were obtained
from the Shanghai Red Cross Blood Center or
from healthy volunteers. The samples from both pa-
tients and controls were chosen randomly. Cytocha-
lasin B (CB), cytochalasin E (CE), phloretin and
N-acetyltryptophanamide (NATA) were purchased
from Sigma. All other reagents were of analytical
grade.
2.2. Erythrocyte preparation
The erythrocytes were washed three times with
PBS (155 mM NaCl, 5 mM sodium phosphate, pH
7.4). In transport study, the erythrocytes were incu-
bated at 37‡C for 30 min with PBS in zero-trans
in£ux measurement or were incubated with PBS con-
taining 80 mM -glucose in in¢nite-cis e¥ux measure-
ment. In inhibitor binding experiment, before trans-
port study the erythrocytes were incubated with PBS
containing inhibitors at 37‡C for 30 min (for CB
binding study, 5 WM CE incubation for 30 min was
performed before CB treatment for competitive in-
hibiting the CB binding site at erythrocyte skeleton
[14]). The treated erythrocytes were kept in ice and
used within 6 h. All measurements were performed at
35‡C besides the temperature dependence study.
2.3. Glucose transport
A modi¢ed Sen and Widdas method [15,16] was
used in D-glucose transport study. For measurement
of zero-trans in£ux, 50 Wl of the treated erythrocytes
(V3U108 cell/ml) was rapidly mixed with 2 ml PBS
containing 200 mM D-glucose in 1 cm cuvette which
contained a stirring bar. The time course of the
change in absorbances of the cell suspension at 660
nm on a spectrometer (type 722, Shanghai No. 3
Analytical Instrument Factory) was measured. The
spectrometer was modi¢ed to set up a magnetic stir-
rer at the bottom of the photometric cell holder and
the circular water around the cell was used. The out-
put electrical signal was through 12 bit A/D convert-
er fed to a microcomputer. The sampling point for
each measurement was 1000. The initial transport
rate V0 was determined from the recorded curve
(Fig. 1A) and ¢tting over 5 times of measurement,
















where Cs is glucose concentration in the cell, OD0 is
the absorbance of the cell suspension at the begin-
ning of the cell shrinkage when the erythrocytes were
put into the medium containing C concentration of
glucose, and ODr is the absorbance after a long time
while the glucose concentration on both sides of the
membrane reaches an equilibrium state.
BBAMEM 77841 15-5-00
X.-j. Hu et al. / Biochimica et Biophysica Acta 1466 (2000) 306^314 307
For measurement of in¢nite-cis e¥ux, the treated
erythrocytes were injected into 1 cm cuvette contain-
ing only 2 ml PBS. The initial rate of glucose e¥ux,
Vm, can be determined from the curve of absorbance
vs. time (Fig. 1B) as previously described [16].
2.4. Temperature dependence
The activation energy for glucose transport in the
temperature region of 20^40‡C can be obtained from
an equation deduced from Arrhenius equation [18]:
ln V  3 E
RT
 lnV273 K  E273 R 2
where V is the transport rate at temperature of T,
V273 K is transport rate at 273 K, E is transport acti-
vation energy and R is the gas constant.
2.5. CB and phloretin inhibition
When there is an inhibitor I, according to the glu-
cose transport kinetic equation of Michaelis^Menten,




 1 I 
K i
3
where Vp and V are transport rate without and with
inhibitor, respectively. [I] is inhibitor concentration.
The Ki is apparent inhibitory constant and it can be
obtained from the slope of a plot of 1/V vs. [I].
2.6. Intrinsic £uorescence quench of white-stripped
ghosts
2.6.1. Preparation of white-stripped ghosts
In order to reduce the £uorescence contribution
from other than membrane proteins, the erythrocytes
were prepared into white-stripped ghosts, which were
prepared as a modi¢cation of Carruthers [20]. After
washing three times with PBS, the erythrocytes at
1:20 (v/v) were hemolyzed in 5P7.4 (5 mM sodium
phosphate, pH 7.4) at 4‡C for 30 min. When mem-
brane fraction became a pearly white appearance
after several times washing and centrifuging at
25 000Ug, they were exposed to ice-cold 5P12.0 (5
mM sodium phosphate, pH adjusted to 12.0 by add-
ing dilute NaOH) for 20 s to deplete peripheral pro-
teins. After washing o¡ alkaline by 5P7.4 the ghosts
were frozen rapidly and thawed three times, and then
stored at 325‡C in 5P7.4. In our experimental con-
dition, there were still a minor peripheral proteins on
the ghosts as checked by SDS-PAGE (data not
shown). But it did not interfere the £uorescence
quench study because we needed only the value of
£uorescence change after binding the inhibitors with
GLUT1. The membrane protein concentration was
calibrated according to Lowry et al. [21].
2.6.2. Fluorescence measurements
Fluorescence measurements were performed at
35‡C with a Hitachi M850 spectro£uorometer. The
wavelength of excitation was 295 nm with a band-
width of 3 nm and the emission was at 340 nm with a
bandwidth of 8 nm to minimize the contribution of
tyrosine residues. A 310-nm ¢lter was used. Fifty
microliters of D-glucose or transport inhibitors were
injected into 2 ml ghosts with 120 Wg total membrane
proteins in a 1-cm cuvette with a stirrer.
2.6.3. Data analysis
The unspeci¢c e¡ects of dilution, inner ¢lter and
ligands £uorescence reabsorption were corrected by a
standard, NATA, which was measured as a function
of added ligand [20,22].
When there are two kinds of luminescence in £uo-
rescence quench, just as in glucose transporter, some
tryptophan residues in hydrophilic and others in hy-
drophobic circumstance, a part quench factor f was
introduced in the Stern^Volmer equation [23]:
Table 1
Initial glucose transport rate across the erythrocyte membranes at 35‡C from 25 healthy human and 30 type 2 diabetic patients
Sample In£ux rate V0 (mM/min) E¥ux rate Vm (mM/min)
Healthy control (n = 25) 40.56 þ 9.04 251.92 þ 50.38
Type 2 diabetic patients (n = 30) 31.36 þ 13.67a 250.03 þ 51.47
Values are the mean þ S.D. Student’s t-test was employed to compare the di¡erence between means.
aP6 0.01 as compared with controls.
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where vF( = F03F) is £uorescence change as quench-
er [Q] binding, F0 and F are the £uorescence intensity
with and without quencher, respectively. Kq is appar-
ent quenching constant and can be obtained from a
double reciprocal plot [24].
3. Results
We have measured 25 healthy blood samples and
30 Chinese type 2 diabetic patient erythrocytes. The
results of glucose transport across the erythrocyte
membranes are shown in Table 1. As can be seen,
the glucose entry rate in patient erythrocytes was
reduced to 77% of the controls, but no signi¢cant
di¡erence was observed for the glucose e¥ux. The
result is in accordance with Comi and Hamilton
[11], but con£icts with Bistritzer et al. [12], whose
result was obtained from nine black female patients.
The activation energy for glucose transport can be
obtained from the Arrhenius plot (Eq. 2). We exam-
ined the temperature dependence of glucose trans-
port of six patients and ¢ve healthy controls. The
result is summarized in Table 2. It shows that the
activation energy of glucose entry for the patient
glucose transporter was increased by 32% over the
controls, which is in reasonable agreement with the
change in the rate of glucose entry for the patient
erythrocytes as shown in Table 1. But the activation
energy for glucose e¥ux has no signi¢cant di¡erence,
though the mean value for patients increased slightly
as compared with healthy erythrocytes (Table 2).
CB causes an inhibition e¡ect for glucose trans-
Fig. 1. Time course of D-glucose zero-trans in£ux (A) and in¢nite-cis e¥ux (B) across the erythrocyte membranes at 35‡C. The ordi-
nate gives the absorbance of cell suspension at 660 nm during glucose transport. The records are the accumulation of at least ¢ve
identical experiments. The D-glucose concentration in the medium was 200 mM in record A, and glucose concentration inside the
erythrocytes was 80 mM in record B. The glucose transport rate can be calculated from these record curves as described in Section 2.
Table 2
The activation energy for glucose transport in the erythrocytes of ¢ve healthy controls and six type 2 diabetic patients
Sample Activation energy (kJ/mol)
Glucose in£ux Glucose e¥ux
Healthy controls (n = 5) 58.89 þ 4.89 76.54 þ 18.51
Type 2 diabetic patients (n = 6) 77.53 þ 8.87a 91.94 þ 19.82
The temperature region is from 20 to 40‡C. Values are the mean þ S.D. Student’s t-test was employed to compare the di¡erence be-
tween means.
aP6 0.01 as compared with controls.
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port after binding to the intracellular domain of
GLUT1. Fig. 2 shows the relationship between the
reciprocal of transport rate and CB concentration.
The CB inhibitory constant of glucose entry in 10
patients was 0.46 þ 0.27 WM, which had no signi¢cant
di¡erence as compared with the value of 0.53 þ 0.40
WM for six healthy controls. For glucose e¥ux, the
inhibitory constants also had no signi¢cant di¡er-
ence: 0.81 þ 0.34 WM for patients and 1.00 þ 0.45
WM for controls.
Phloretin is another kind of inhibitor of glucose
transport across the erythrocyte membranes. The ap-
parent inhibitory constant for glucose entry in six
patients was 8.05 þ 4.27 WM, but even 10 WM phlor-
etin had no signi¢cant inhibition e¡ect on the glucose
entry in another six patient erythrocytes. The phlor-
etin inhibitory constant for glucose entry in 11
healthy controls was 2.14 þ 1.56 WM. The inhibitory
constant for glucose e¥ux in 11 healthy controls was
10.02 þ 4.33 WM and 9.75 þ 1.87 WM for 12 diabetic
patients.
Fig. 3 shows the excitation and emission spectra of
white stripped ghosts. There was no spectrum di¡er-
ence between the controls and patients, and the spec-
tra are mainly contributed by the tryptophan resi-
dues of the ghosts. Fig. 4 shows the relationship of
reciprocal of £uorescence change with reciprocal of
quencher concentration. The apparent quench con-
stants calculated from Fig. 4 are shown in Table 3.
The concentrations of glucose, CB and phloretin in
study are 10^350 mM, 2^15 WM and 0.5^4 WM, re-
spectively. As compared with healthy ghosts, it was
shown that the apparent quench constant by glucose
Fig. 2. Inhibitory e¡ect of CB on glucose zero-trans in£ux (A) and in¢nite-cis e¥ux (B) for healthy controls (circle) and type 2 dia-
betic patients (triangle). Mean values and standard deviation are indicated from six control and ten patient determinations.
Fig. 3. The excitation (A) and emission (B) spectra of stripped
white ghosts from a healthy control (solid) and a type 2 dia-
betic patients (dash) ghosts.
Table 3
The apparent quench constants, Kq, for the ghosts of 6 healthy
controls and 10 type 2 diabetic patients at 35‡C
Quencher Quench constant Kq (M31)
Control ghosts Diabetic ghosts
Glucose 15.68 þ 1.01 10.59 þ 1.54a
CB (6.96 þ 0.84)U103 (48.02 þ 9.12)U103b
Phloretin (1.04 þ 0.24)U105 (1.77 þ 0.19)U105a
Values are the mean þ S.D. 120Wg of total membrane proteins
were used in each measurement. Student’s t-test was employed
to compare the di¡erence between means.
aP6 0.01 as compared with controls.
bP6 0.001 as compared with controls.
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for patients was decreased to about 40%, and the
apparent quench constants by CB and phloretin
were increased by 6-fold and 70%, respectively.
4. Discussion
The present results reveal that the rate of glucose
entry was decreased in the erythrocyte membranes of
Chinese type 2 diabetic patients as compared to the
controls. The possible reasons would be as follows:
(1) the alteration of the phospholipid bilayers in dia-
betes erythrocyte membranes; (2) change in GLUT1
content; (3) abnormality of other proteins in the
erythrocyte membranes; and (4) the alteration of
structure or conformation of GLUT1. We prefer
the fourth reason as a most important factor.
The lipid^protein interaction can change the activ-
ity of membrane proteins [25,26] and it was reported
that GLUT1 has some preferential a⁄nity for speci¢c
lipid [27]. It was also reported that there were some
changes in lipid component, sti¡ness and £uidity of
diabetic erythrocyte membranes [28^30]. But our
studies show that in patient erythrocytes there was
no signi¢cant change in glucose e¥ux (Table 1), there
was no signi¢cant change in the activation energy for
glucose e¥ux (Table 2), the increase in activation en-
ergy for glucose entry was in accordance with the
decrease in entry rate. These results suggest that the
membrane surroundings play minor roles in the alter-
ation of glucose transport in patient erythrocytes.
It was reported that GLUT1 content had been
increased by about 50% [31] in human ¢broblasts
and skeletal muscle from the plasma membrane of
non-insulin-dependent diabetes and obese subjects,
and in skeletal muscle of streptozocin-induced dia-
betic rats [32]. As in human erythrocytes, though
Harik et al. [33] reported that chronic hyperglycemia
increased the density of GLUT1, there was no fur-
ther study to support the result. Other reports
showed that the content of GLUT1 had no changed
in diabetic erythrocytes and our unpublished SDS-
PAGE data also supported this. Moreover, an in-
crease in the density of GLUT1 could not explain
why glucose entry was a¡ected and e¥ux was not.
The content alteration of GLUT1 does not explain
Fig. 4. Double reciprocal plots of GLUT1 £uorescence quench
in the presence of glucose (A), CB (B) and phloretin (C). Mean
values and standard deviation are indicated from six control
(circle) and 10 patient (triangle) determinations. The apparent
£uorescence quench constants can be obtained from the plots
as described in Section 2.
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the result of the temperature dependence study (Ta-
ble 2) because these results did not depend on the
protein contents.
Some other membrane proteins can change the
activity of GLUT1 through ‘protein^protein’ interac-
tion. Of particular interest is band 3. Bosman and
Kay [34] reported that cells with an increased (sensi-
tivity to) breakdown of band 3 protein display an
increased asymmetry of glucose transport. We have
also described that an increase in the concentration
of Cl3 (the substrate of band 3) in the medium
caused an increase in in¢nite-cis e¥ux of glucose
transport [35]. Our study showed that the NO32
transport mediated by band 3 in the erythrocyte
membranes has no signi¢cant di¡erence between
Chinese type 2 diabetic patients and the controls
(data not shown). Insulin receptors are another im-
portant protein for glucose transporter activity. Lon-
go et al. [36] reported that a mutation in arginine-86
of the insulin receptor can increase glucose transport,
but there was not enough information to demon-
strate the defect of this protein in diabetes. Tegos
and Beutler [37] reported that the glycolytic inter-
mediates in diabetes erythrocytes were altered as
compared with healthy control, but no evidence for
hormonal or metabolic regulation of sugar transport
had been obtained.
Regarding the factor of the individual age, Forbes
et al. [3] found that glucose uptake was reduced by
about 20% in type 2 diabetic patients when using
healthy elderly controls. Magnani et al. [38] reported
that human erythrocytes of di¡erent age possess sim-
ilar abilities to transport glucose [38]. Our measure-
ment also indicated that the zero-trans entry rate has
no signi¢cant relevance to sex and age for adults
(data not shown). So that the age-dependent factor
in glucose transport can be exclude.
Phloretin is an inhibitor of glucose transporter,
which is bound to the extracellular domain of
GLUT1. Our experiment showed that the inhibitory
constant was increased after phloretin treatment, but
no such change was observed for CB treatment. The
result strongly supports that the decrease in glucose
entry in the erythrocyte membranes of Chinese type
2 diabetic patients was due to the GLUT1 structure
change ^ mostly the outer domain of the glucose
transporter.
GLUT1 consists of 492 amino acid residues which
spans the membrane bilayer at least 12 times. There
are six tryptophan residues in the GLUT1, among
them four tryptophan residues are located in the hy-
drophobic environment and another two tryptophan
residues are in the hydrophilic environment [39].
GLUT1 alters its conformation after binding with
glucose, CB or phloretin so that the intensity and
the emission peak of the tryptophan £uorescence
will be changed. The £uorescence intensity will de-
crease after the tryptophan residue moves from the
hydrophilic environment to the hydrophobic envi-
ronment [40]. The abnormality of £uorescence
quenches in the erythrocyte membranes of patients
was observed in our experiment (Fig. 4). Because the
£uorescence quench came from binding of GLUT1
with their speci¢c inhibitors or substrates, so we can
exclude the contribution of the tryptophan residues
of other membrane proteins from the value of £uo-
rescence change (vF). On account of the lack of a
suitable method to eliminate the scattering e¡ect of
the ghosts from the intrinsic £uorescence, the total
amount of membrane proteins for each sample of
both patients and controls was the same in the ex-
periment. Under this condition, It was still possible
to estimate the apparent quench constant according
to Eq. 5 from Fig. 4 even if we did not know the
exact value of F0. The transfer tendency of trypto-
phan residues from the hydrophilic environment to
the hydrophobic environment was decreased in pa-
tient erythrocyte membranes as binding with glucose,
and the opposite tendency was observed as CB and
phloretin instead of glucose (Fig. 4 and Table 3).
There was no e¡ect of freeze^thawing on the £uores-
cence analysis results, as this became a routine meth-
od of sample preparation for £uorescence experi-
ments [20,41].
The regulation of glucose transport is through an
unknown signal [42] in response to increased meta-
bolic demand, such as inhibition of oxidative phos-
phorylation and glucose starvation in diabetes. The
defect of glucose transport in diabetes can take place
at this signal pathway. Condorelli et al. [43] reported
that PED/PEA-15 gene can increase the content of
GLUT1 in diabetes. Our study suggested that the
GLUT1 itself has been changed in diabetes erythro-
cyte membranes, and the altered site is mostly at the
outer domain rather than the inner domain of the
GLUT1 protein.
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